FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Larry Augsburger

Research Profile

Chemicals & Drugs

Occupations

Concepts & Ideas

Procedures

Drug Compounding

Co-author Network

Publications

TOP 3
Huijeong Ashley Jung; Larry L Augsburger
Application of a novel automatic disintegration apparatus for the development and evaluation of a direct compression rapidly disintegrating tablet.
Stuart L Cantor; Stephen W. Hoag; Larry L Augsburger
Evaluation of the mechanical properties of extrusion-spheronized beads and multiparticulate systems.
Stuart L Cantor; Stephen W. Hoag; Larry L Augsburger
Formulation and characterization of a compacted multiparticulate system for modified release of water-soluble drugs--part 1--acetaminophen.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Larry Augsburger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Huijeong Ashley Jung; Larry L Augsburger
Application of a novel automatic disintegration apparatus for the development and evaluation of a direct compression rapidly disintegrating tablet.
Drug development and industrial pharmacy 2012;38(7):825-36.
2009: Stuart L Cantor; Stephen W. Hoag; Larry L Augsburger
Evaluation of the mechanical properties of extrusion-spheronized beads and multiparticulate systems.
Drug development and industrial pharmacy 2009;35(6):683-93.
2009: Stuart L Cantor; Stephen W. Hoag; Larry L Augsburger
Formulation and characterization of a compacted multiparticulate system for modified release of water-soluble drugs--part 1--acetaminophen.
Drug development and industrial pharmacy 2009;35(3):337-51.
2008: Lin Xie; Huiquan Wu; Meiyu Shen; Larry L Augsburger; Robbe C Lyon; Mansoor A Khan; Ajaz Hussain; Stephen W. Hoag
Quality-by-design (QbD): effects of testing parameters and formulation variables on the segregation tendency of pharmaceutical powder measured by the ASTM D 6940-04 segregation tester.
Journal of pharmaceutical sciences 2008;97(10):4485-97.
2008: Xiaohong Pan; Thomas Julian; Larry L Augsburger
Increasing the dissolution rate of a low-solubility drug through a crystalline-amorphous transition: a case study with indomethacin [correction of indomethicin].
Drug development and industrial pharmacy 2008;34(2):221-31.
2008: Ping Jin; Shadi Madieh; Larry L Augsburger
Selected physical and chemical properties of Feverfew (Tanacetum parthenium) extracts important for formulated product quality and performance.
AAPS PharmSciTech 2008;9(1):22-30.
2007: Shadi Madieh; Michael Simone; Wendy Wilson; Dev Mehra; Larry L Augsburger
Investigation of drug-porous adsorbent interactions in drug mixtures with selected porous adsorbents.
Journal of pharmaceutical sciences 2007;96(4):851-63.
2007: Ping Jin; Shadi Madieh; Larry L Augsburger
The solution and solid state stability and excipient compatibility of parthenolide in feverfew.
AAPS PharmSciTech 2007;8(4):E105.
2006: Na Zhao; Larry L Augsburger
The influence of granulation on super disintegrant performance.
Pharmaceutical development and technology 2006;11(1):47-53.
2006: Na Zhao; Larry L Augsburger
The influence of product brand-to-brand variability on superdisintegrant Performance. A case study with croscarmellose sodium.
Pharmaceutical development and technology 2006;11(2):179-85.
2006: Xiaohong Pan; Thomas Julian; Larry L Augsburger
Quantitative measurement of indomethacin crystallinity in indomethacin-silica gel binary system using differential scanning calorimetry and X-ray powder diffractometry.
AAPS PharmSciTech 2006;7(1):E11.
2005: Wendy I Wilson; Yun Peng; Larry L Augsburger
Comparison of statistical analysis and Bayesian Networks in the evaluation of dissolution performance of BCS Class II model drugs.
Journal of pharmaceutical sciences 2005;94(12):2764-76.
2005: Na Zhao; Larry L Augsburger
Functionality comparison of 3 classes of superdisintegrants in promoting aspirin tablet disintegration and dissolution.
AAPS PharmSciTech 2005;6(4):E634-40.
2005: Wendy I Wilson; Yun Peng; Larry L Augsburger
Generalization of a prototype intelligent hybrid system for hard gelatin capsule formulation development.
AAPS PharmSciTech 2005;6(3):E449-57.
2005: Na Zhao; Larry L Augsburger
The influence of swelling capacity of superdisintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressed tablets.
AAPS PharmSciTech 2005;6(1):E120-6.
2004: Aditya S Tatavarti; Ketan A Mehta; Larry L Augsburger; Stephen W. Hoag
Influence of methacrylic and acrylic acid polymers on the release performance of weakly basic drugs from sustained release hydrophilic matrices.
Journal of pharmaceutical sciences 2004;93(9):2319-31.
2003: Angela Y Lin; Nouman A Muhammad; David Pope; Larry L Augsburger
A study of the effects of curing and storage conditions on controlled release diphenhydramine HCl pellets coated with Eudragit NE30D.
Pharmaceutical development and technology 2003;8(3):277-87.
2003: Mintong Guo; Larry L Augsburger
Potential application of silicified microcrystalline cellulose in direct-fill formulations for automatic capsule-filling machines.
Pharmaceutical development and technology 2003;8(1):47-59.
2002: Marilyn Martinez; Larry L Augsburger; Thomas Johnston; Wendelyn Warren Jones
Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part I: biopharmaceutics and formulation considerations.
Advanced drug delivery reviews 2002;54(6):805-24.
2002: Susan H Kopelman; Larry L Augsburger
Excipient compatibility study of Hypericum perforatum extract (St. John's wort) using similarity metrics to track phytochemical profile changes.
International journal of pharmaceutics 2002;237(1-2):35-46.
2002: Mintong Guo; Francis X Muller; Larry L Augsburger
Evaluation of the plug formation process of silicified microcrystalline cellulose.
International journal of pharmaceutics 2002;233(1-2):99-109.
2002: Y S Habib; Larry L Augsburger; R F Shangraw
Production of inert cushioning beads: effect of excipients on the physicomechanical properties of freeze-dried beads containing microcrystalline cellulose produced by extrusion-spheronization.
International journal of pharmaceutics 2002;233(1-2):67-83.
2002: Pavan K Heda; Kapiamba Muteba; Larry L Augsburger
Comparison of the formulation requirements of dosator and dosing disc automatic capsule filling machines.
AAPS pharmSci 2002;4(3):E17.
2002: Umang Shah; Larry L Augsburger
Multiple sources of sodium starch glycolate, NF: evaluation of functional equivalence and development of standard performance tests.
Pharmaceutical development and technology 2002;7(3):345-59.
2002: Nattee Sirisuth; Larry L Augsburger; Natalie D. Eddington
Development and validation of a non-linear IVIVC model for a diltiazem extended release formulation.
Biopharmaceutics & drug disposition 2002;23(1):1-8.
2001: R Kuppuswamy; S R Anderson; Stephen W. Hoag; Larry L Augsburger
Practical limitations of tableting indices.
Pharmaceutical development and technology 2001;6(4):505-20.
2001: S H Kopleman; A NguyenPho; W S Zito; F X Muller; Larry L Augsburger
Selected physical and chemical properties of commercial Hypericum perforatum extracts relevant for formulated product quality and performance.
AAPS pharmSci 2001;3(4):E26.
2001: A Y Lin; N A Muhammad; D Pope; Larry L Augsburger
Study of crystallization of endogenous surfactant in Eudragit NE30D-free films and its influence on drug-release properties of controlled-release diphenhydramine HCl pellets coated with Eudragit NE30D.
AAPS pharmSci 2001;3(2):E14.
2001: R Kuppuswamy; S R Anderson; Larry L Augsburger; Stephen W. Hoag
Estimation of capping incidence by indentation fracture tests.
AAPS pharmSci 2001;3(1):E5.
2001: U Shah; Larry L Augsburger
Evaluation of the functional equivalence of crospovidone NF from different sources. I. Physical characterization.
Pharmaceutical development and technology 2001;6(1):39-51.
2000: H Mahayni; GS Rekhi; Ramana S Uppoor; Patrick J Marroum; Ajaz Hussain; Larry L Augsburger; Natalie D. Eddington
Evaluation of "external" predictability of an in vitro-in vivo correlation for an extended-release formulation containing metoprolol tartrate.
Journal of pharmaceutical sciences 2000;89(10):1354-61.
2000: Natalie D. Eddington; GS Rekhi; Lawrence J Lesko; Larry L Augsburger
Scale-up effects on dissolution and bioavailability of propranolol hydrochloride and metoprolol tartrate tablet formulations.
AAPS PharmSciTech 2000;1(2):E14.
1999: GS Rekhi; R V Nellore; Ajaz Hussain; L G Tillman; H J Malinowski; Larry L Augsburger
Identification of critical formulation and processing variables for metoprolol tartrate extended-release (ER) matrix tablets.
Journal of controlled release : official journal of the Controlled Release Society 1999;59(3):327-42.
1999: P K Heda; Francis X Muller; Larry L Augsburger
Capsule filling machine simulation. I. Low-force powder compression physics relevant to plug formation.
Pharmaceutical development and technology 1999;4(2):209-19.
1999: H Hahm; J Kujawa; Larry L Augsburger
Comparison of melatonin products against USP's nutritional supplements standards and other criteria.
Journal of the American Pharmaceutical Association (Washington,D.C. : 1996) 1999;39(1):27-31.
1998: Natalie D. Eddington; M Ashraf; Larry L Augsburger; J L Leslie; Michael Fossler; Lawrence J Lesko; Vinod P Shah; GS Rekhi
Identification of formulation and manufacturing variables that influence in vitro dissolution and in vivo bioavailability of propranolol hydrochloride tablets.
Pharmaceutical development and technology 1998;3(4):535-47.
1998: DA Piscitelli; S Bigora; C Propst; S Goskonda; P Schwartz; Lawrence J Lesko; Larry L Augsburger; D Young
The impact of formulation and process changes on in vitro dissolution and the bioequivalence of piroxicam capsules.
Pharmaceutical development and technology 1998;3(4):443-52.
1998: Natalie D. Eddington; Patrick J Marroum; Ramana S Uppoor; A Hussain; Larry L Augsburger
Development and internal validation of an in vitro-in vivo correlation for a hydrophilic metoprolol tartrate extended release tablet formulation.
Pharmaceutical research 1998;15(3):466-73.
1998: R V Nellore; GS Rekhi; Ajaz Hussain; L G Tillman; Larry L Augsburger
Development of metoprolol tartrate extended-release matrix tablet formulations for regulatory policy consideration.
Journal of controlled release : official journal of the Controlled Release Society 1998;50(1-3):247-56.
1997: James E. Polli; GS Rekhi; Larry L Augsburger; Vinod P Shah
Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets.
Journal of pharmaceutical sciences 1997;86(6):690-700.
1997: GS Rekhi; Natalie D. Eddington; Michael Fossler; P Schwartz; Lawrence J Lesko; Larry L Augsburger
Evaluation of in vitro release rate and in vivo absorption characteristics of four metoprolol tartrate immediate-release tablet formulations.
Pharmaceutical development and technology 1997;2(1):11-24.
1996: J Z Li; GS Rekhi; Larry L Augsburger; R F Shangraw
The role of intra- and extragranular microcrystalline cellulose in tablet dissolution.
Pharmaceutical development and technology 1996;1(4):343-55.
1996: R M Iyer; Larry L Augsburger; D G Pope; R D Shah
Extrusion/spheronization--effect of moisture content and spheronization time on pellet characteristics.
Pharmaceutical development and technology 1996;1(4):325-31.
1996: Y Habib; Larry L Augsburger; G Reier; T Wheatley; R Shangraw
Dilution potential: a new perspective.
Pharmaceutical development and technology 1996;1(2):205-12.
1995: R D Shah; M Kabadi; D G Pope; Larry L Augsburger
Physico-mechanical characterization of the extrusion-spheronization process. Part II: Rheological determinants for successful extrusion and spheronization.
Pharmaceutical research 1995;12(4):496-507.
1995: J J Torrado-Durán; Susana Torrado; R Cadórniga; Larry L Augsburger
Tableting characteristics of micro-aggregated egg albumin particles containing paracetamol.
The Journal of pharmacy and pharmacology 1995;47(2):115-9.
1994: F X Muller; Larry L Augsburger
The role of the displacement-time waveform in the determination of Heckel behaviour under dynamic conditions in a compaction simulator and a fully-instrumented rotary tablet machine.
The Journal of pharmacy and pharmacology 1994;46(6):468-75.
1994: M Ashraf; V L Iuorno; D Coffin-Beach; C A Evans; Larry L Augsburger
A novel nuclear magnetic resonance (NMR) imaging method for measuring the water front penetration rate in hydrophilic polymer matrix capsule plugs and its role in drug release.
Pharmaceutical research 1994;11(5):733-7.
1994: J P Skelly; G A Van Buskirk; H M Arbit; Gordon L Amidon; Larry L Augsburger; W H Barr; S Berge; J Clevenger; S Dighe; M Fawzi
Workshop II report: scaleup of oral extended release dosage forms.
Journal of pharmaceutical science and technology : the official journal of PDA 1994;48(2):95-101.
1994: R D Shah; M Kabadi; D G Pope; Larry L Augsburger
Physicomechanical characterization of the extrusion-spheronization process. I. Instrumentation of the extruder.
Pharmaceutical research 1994;11(3):355-60.
1993: J P Skelly; G A Van Buskirk; H M Arbit; Gordon L Amidon; Larry L Augsburger; W H Barr; S Berge; J Clevenger; S Dighe; M Fawzi
Scaleup of oral extended-release dosage forms.
Pharmaceutical research 1993;10(12):1800-5.
1992: V Corvari; W C Fry; W L Seibert; Larry L Augsburger
Instrumentation of a high-shear mixer: evaluation and comparison of a new capacitive sensor, a watt meter, and a strain-gage torque sensor for wet granulation monitoring.
Pharmaceutical research 1992;9(12):1525-33.
1990: Arun KOPARKAR; Larry L Augsburger; R F Shangraw
Intrinsic dissolution rates of tablet filler-binders and their influence on the dissolution of drugs from tablet formulations.
Pharmaceutical research 1990;7(1):80-6.
1988: A R Baichwal; Larry L Augsburger
Variations in the friction coefficients of tablet lubricants and relationship to their physicochemical properties.
The Journal of pharmacy and pharmacology 1988;40(8):569-71.
1987: K B Shah; Larry L Augsburger; K Marshall
Multiple tamping effects on drug dissolution from capsules filled on a dosing-disk type automatic capsule filling machine.
Journal of pharmaceutical sciences 1987;76(8):639-45.
1986: K B Shah; Larry L Augsburger; K Marshall
An investigation of some factors influencing plug formation and fill weight in a dosing disk-type automatic capsule-filling machine.
Journal of pharmaceutical sciences 1986;75(3):291-6.
1984: J E Botzolakis; Larry L Augsburger
The role of disintegrants in hard-gelatin capsules.
The Journal of pharmacy and pharmacology 1984;36(2):77-84.
1983: Larry L Augsburger; R F Shangraw; R P Giannini; Vinod P Shah; V K Prasad; D Brown
Thiazides. VIII: Dissolution survey of marketed hydrochlorothiazide tablets.
Journal of pharmaceutical sciences 1983;72(8):876-81.
1977: L E Small; Larry L Augsburger
Clarification of nomenclature.
Journal of pharmaceutical sciences 1977;66(10):1508.
1977: L E Small; Larry L Augsburger
Instrumentation of an automatic capsule-filling machine.
Journal of pharmaceutical sciences 1977;66(4):504-9.
1977: S T David; Larry L Augsburger
Plastic flow during compression of directly compressible fillers and its effect on tablet strength.
Journal of pharmaceutical sciences 1977;66(2):155-9.
1974: S T David; Larry L Augsburger
Flexure test for determination of tablet tensile strength.
Journal of pharmaceutical sciences 1974;63(6):933-6.
1974: A M Salpekar; Larry L Augsburger
Magnesium lauryl sulfate in tableting: effect on ejection force and compressibility.
Journal of pharmaceutical sciences 1974;63(2):289-93.
1970: K R Vora; Larry L Augsburger; R F Shangraw
Design and evaluation of a pressure attachment for a rotational rheometer.
Journal of pharmaceutical sciences 1970;59(7):1012-6.
1968: Larry L Augsburger; R F Shangraw
Bubble size analysis of high consistency aerosol foams and its relationship to foam rheology. Effects of container emptying, propellent type, and time.
Journal of pharmaceutical sciences 1968;57(4):624-31.
1966: Larry L Augsburger; R F Shangraw
Effect of glidants in tableting.
Journal of pharmaceutical sciences 1966;55(4):418-23.